American Century Companies’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Buy |
17,548
+112
| +0.6% | +$5.45K | ﹤0.01% | 2350 |
|
|
2025
Q1 | $593K | Sell |
17,436
-23
| -0.1% | -$783 | ﹤0.01% | 2447 |
|
|
2024
Q4 | $687K | Sell |
17,459
-848
| -5% | -$33.4K | ﹤0.01% | 2394 |
|
|
2024
Q3 | $860K | Sell |
18,307
-104
| -0.6% | -$4.89K | ﹤0.01% | 2288 |
|
|
2024
Q2 | $994K | Buy |
18,411
+703
| +4% | +$38K | ﹤0.01% | 2179 |
|
|
2024
Q1 | $1.21M | Buy |
17,708
+3,015
| +21% | +$206K | ﹤0.01% | 2067 |
|
|
2023
Q4 | $920K | Buy |
14,693
+961
| +7% | +$60.2K | ﹤0.01% | 2105 |
|
|
2023
Q3 | $623K | Buy |
13,732
+1,223
| +10% | +$55.5K | ﹤0.01% | 2188 |
|
|
2023
Q2 | $702K | Buy |
12,509
+751
| +6% | +$42.2K | ﹤0.01% | 2075 |
|
|
2023
Q1 | $529K | Buy |
11,758
+1,282
| +12% | +$57.6K | ﹤0.01% | 2109 |
|
|
2022
Q4 | $426K | Buy |
10,476
+1,762
| +20% | +$71.6K | ﹤0.01% | 2101 |
|
|
2022
Q3 | $570K | Sell |
8,714
-200,553
| -96% | -$13.1M | ﹤0.01% | 1910 |
|
|
2022
Q2 | $12.7M | Buy |
+209,267
| New | +$12.7M | 0.01% | 827 |
|
|
2022
Q1 | – | Sell |
-375,854
| Closed | -$28.5M | – | 2299 |
|
|
2021
Q4 | $28.5M | Sell |
375,854
-908
| -0.2% | -$68.8K | 0.02% | 608 |
|
|
2021
Q3 | $42.2M | Sell |
376,762
-70
| -0% | -$7.84K | 0.03% | 494 |
|
|
2021
Q2 | $61M | Buy |
376,832
+98,017
| +35% | +$15.9M | 0.04% | 426 |
|
|
2021
Q1 | $34M | Sell |
278,815
-83,614
| -23% | -$10.2M | 0.03% | 517 |
|
|
2020
Q4 | $55.5M | Sell |
362,429
-317,991
| -47% | -$48.7M | 0.04% | 375 |
|
|
2020
Q3 | $56.9M | Buy |
680,420
+199,720
| +42% | +$16.7M | 0.05% | 329 |
|
|
2020
Q2 | $35.3M | Buy |
480,700
+364,764
| +315% | +$26.8M | 0.03% | 402 |
|
|
2020
Q1 | $4.92M | Buy |
+115,936
| New | +$4.92M | 0.01% | 728 |
|